ETC
Exchange Traded Concepts’s West Pharmaceutical WST Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $68.5K | Sell |
313
-18
| -5% | -$3.94K | ﹤0.01% | 1286 |
|
|
2025
Q1 | $74.1K | Buy |
331
+92
| +38% | +$20.6K | ﹤0.01% | 1205 |
|
|
2024
Q4 | $78.3K | Buy |
239
+38
| +19% | +$12.4K | ﹤0.01% | 1181 |
|
|
2024
Q3 | $60.3K | Sell |
201
-630
| -76% | -$189K | ﹤0.01% | 1180 |
|
|
2024
Q2 | $274K | Sell |
831
-2,151
| -72% | -$709K | 0.01% | 835 |
|
|
2024
Q1 | $1.18M | Buy |
2,982
+1,810
| +154% | +$716K | 0.03% | 406 |
|
|
2023
Q4 | $413K | Buy |
1,172
+1,043
| +809% | +$367K | 0.01% | 675 |
|
|
2023
Q3 | $48.4K | Sell |
129
-1,149
| -90% | -$431K | ﹤0.01% | 1037 |
|
|
2023
Q2 | $489K | Buy |
1,278
+265
| +26% | +$101K | 0.01% | 620 |
|
|
2023
Q1 | $351K | Sell |
1,013
-144
| -12% | -$49.9K | 0.01% | 673 |
|
|
2022
Q4 | $272K | Buy |
1,157
+114
| +11% | +$26.8K | 0.01% | 687 |
|
|
2022
Q3 | $257K | Buy |
1,043
+225
| +28% | +$55.4K | 0.01% | 654 |
|
|
2022
Q2 | $247K | Sell |
818
-7,611
| -90% | -$2.3M | 0.01% | 719 |
|
|
2022
Q1 | $3.46M | Buy |
8,429
+7,299
| +646% | +$3M | 0.07% | 154 |
|
|
2021
Q4 | $530K | Buy |
1,130
+505
| +81% | +$237K | 0.01% | 663 |
|
|
2021
Q3 | $265K | Sell |
625
-1,507
| -71% | -$639K | 0.01% | 714 |
|
|
2021
Q2 | $766K | Buy |
2,132
+532
| +33% | +$191K | 0.02% | 379 |
|
|
2021
Q1 | $451K | Sell |
1,600
-66
| -4% | -$18.6K | 0.02% | 599 |
|
|
2020
Q4 | $472K | Buy |
1,666
+101
| +6% | +$28.6K | 0.02% | 379 |
|
|
2020
Q3 | $430K | Sell |
1,565
-35
| -2% | -$9.62K | 0.02% | 334 |
|
|
2020
Q2 | $363K | Buy |
1,600
+1,562
| +4,111% | +$354K | 0.06% | 261 |
|
|
2020
Q1 | $6K | Buy |
38
+6
| +19% | +$947 | ﹤0.01% | 384 |
|
|
2019
Q4 | $5K | Buy |
+32
| New | +$5K | ﹤0.01% | 384 |
|